As of May 25
| -0.03 / -0.50%|
The 1 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 7.25, with a high estimate of 7.25 and a low estimate of 7.25. The median estimate represents a +20.43% increase from the last price of 6.02.
The current consensus among 1 polled investment analysts is to Hold stock in China Cord Blood Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.